Clinical Trial Update: CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether CLCNKA gene polymorphisms influence hypertrophy regression in hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN